Literature DB >> 15297946

Treatment of localized esophageal cancer.

Baruch Brenner1, David H Ilson, Bruce D Minsky.   

Abstract

The treatment of localized esophageal cancer (LEC) is controversial. The approaches that are used in daily practice include surgery or radiation alone, preoperative or postoperative radiation, preoperative or postoperative chemotherapy, and definitive or preoperative chemoradiation. The varied modalities used to treat LEC reflect both the lack of randomized trial data and the suboptimal results with current therapy. Nonetheless, the available data suggest that surgery and definitive concurrent chemoradiation represent two standard treatment options. The use of preoperative chemoradiation remains investigational, with phase III trials failing to demonstrate a consistent benefit for this option over chemoradiation or surgery alone. This review will examine the available data on the current treatment approaches in LEC.

Entities:  

Mesh:

Year:  2004        PMID: 15297946     DOI: 10.1053/j.seminoncol.2004.04.015

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  10 in total

1.  [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].

Authors:  F Lordick
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

2.  The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer.

Authors:  Reza Bagheri; Mohammad Taghi RajabiMashhadi; Kiyarash Ghazvini; Amir Asnaashari; Ali Zahediyan; Mehdi Abasi Sahebi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-05

3.  Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.

Authors:  Michelle A T Hildebrandt; Hushan Yang; Mien-Chie Hung; Julie G Izzo; Maosheng Huang; Jie Lin; Jaffer A Ajani; Xifeng Wu
Journal:  J Clin Oncol       Date:  2009-01-21       Impact factor: 44.544

4.  Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.

Authors:  Maria C Wolf; Franz Zehentmayr; Michael Schmidt; Dieter Hölzel; Claus Belka
Journal:  Radiat Oncol       Date:  2012-04-15       Impact factor: 3.481

Review 5.  Angiogenesis in cancer.

Authors:  Naoyo Nishida; Hirohisa Yano; Takashi Nishida; Toshiharu Kamura; Masamichi Kojiro
Journal:  Vasc Health Risk Manag       Date:  2006

6.  Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Yingyu Liu; Changgui Kou; Yingying Su; Yangyu Zhang; Yueyue You; Lili Zhang; Mohan Wang; Yingli Fu; Xiaojun Ren; Yanming Yang
Journal:  Onco Targets Ther       Date:  2017-06-13       Impact factor: 4.147

7.  • Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

Authors:  Sonja Kappel-Latif; Johannes Zacherl; Michael Hejna; Maria Westerhoff; Dietmar Tamandl; Ahmed Ba-Ssalamah; Martina Mittlböck; Brigitte Wolf; Friedrich Wrba; Irene Kührer; Ursula Pluschnig; Sebastian F Schoppmann; Reinhold Függer; Ronald Zwrtek; Karl Glaser; Josef Karner; Friedrich Längle; Etienne Wenzl; Rudolf Roka; Dietmar Öfner; Jörg Tschmelitsch; Michael Hold; Felix Keil; Michael Gnant; Daniela Kandioler
Journal:  Eur Surg       Date:  2018-06-11       Impact factor: 0.953

8.  Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs.

Authors:  Li Xie; Xianrang Song; Jinming Yu; Ling Wei; Bao Song; Xingwu Wang; Liyan Lv
Journal:  J Exp Clin Cancer Res       Date:  2009-05-27

9.  A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer.

Authors:  Arunima Gupta; Somnath Roy; Anup Majumdar; Avijit Hazra; Chandrani Mallik
Journal:  Indian J Med Paediatr Oncol       Date:  2014-01

10.  Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer.

Authors:  Oran Zlotnik; Tal Goshen-Lago; Riad Haddad; Baruch Brenner; Yulia Kundel; Irit Ben-Aharon; Hanoch Kashtan
Journal:  Cancer Rep (Hoboken)       Date:  2021-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.